Heat shock protein 60 as a novel therapeutic target for diabetes and rheumatoid arthritis (HSPFORTHERAPY)

Informazioni relative al progetto

HSPFORTHERAPY

ID dell’accordo di sovvenzione: QLG1-CT-2002-01287

Progetto chiuso

Data di avvio 1 Settembre 2002

Data di completamento 30 Giugno 2005

Finanziato da

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Costo totale € 1 409 275,00

Contributo UE € 1 299 892,00

Coordinato da

UTRECHT UNIVERSITY
Netherlands

Obiettivo

Heat shock proteins are antigens of immune responses in autoimmunity. In experimental models they suppress inflammation and in clinical trials in diabetes and arthritis hsp60 has a proven therapeutic potential. We propose to analyse the underlying mechanisms by monitoring immunity to hsp60 in the models, in patients and during hsp60 peptide trials, with respect to both the adaptive and the innate part of the immune system.

Campo scientifico

• medical and health sciences › clinical medicine › rheumatology
• natural sciences › biological sciences › biochemistry › biomolecules › proteins
• medical and health sciences › clinical medicine › endocrinology › diabetes
• medical and health sciences › basic medicine › immunology

Programma(i)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Argomento(i)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

CSC - Cost-sharing contracts

Coordinatore

UTRECHT UNIVERSITY

• Contributo UE: Nessun dato
• Indirizzo: Yalelaan 1 ; 3584 CL UTRECHT ; Paesi Bassi
• Costo totale: Nessun dato

Partecipanti (5)

DEUTSCHE DIABETES FORSCHUNGSGESELLSCHAFT E.V.

Germania

• Contributo UE: Nessun dato
• Indirizzo: Auf'm Hennekekamp 65 ; 40225 DUESSELDORF
• Costo totale: Nessun dato

PEPTOR LTD

Israele

• Contributo UE: Nessun dato
• Indirizzo: Kyriat Weizmann, Building 16 ; 76326 REHOVOT
• Costo totale: Nessun dato

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

Regno Unito

• Contributo UE: Nessun dato
• Indirizzo: Hills Road Addenbrooke's NHS Trust 5 ; CB2 2QQ Cambridge
• Costo totale: Nessun dato

UNIVERSITY MEDICAL CENTRE UTRECHT

Paesi Bassi

• Contributo UE: Nessun dato
• Indirizzo: Lundlaan 6 ; 3584EA UTRECHT
• Costo totale: Nessun dato

WEIZMANN INSTITUTE OF SCIENCE

Israele

• Contributo UE: Nessun dato
• Indirizzo: Herzel Street 2 ; 76100 REHOVOT
• Costo totale: Nessun dato